PROSTATE CANCER
- The most common cancer in men in the US after skin cancer
- 2nd leading cancer death cause in the US after lung cancer
- 248,000 new cases in men expected in the US in 2021
- 34,000 deaths expected in the US in 2021
Prostate Cancer Research Program
- Preclinical experiments performed in house
- High quality preclinical data obtained
- Promising antitumor results identified
- Upcoming in-vivo studies
- FDA track: upcoming request for pre-IND Meeting
CLINICAL PATH
- Preclinical POC validation (ongoing)
- Dossier preparation for submission of Pre-IND meeting request with FDA
